{"id":2394,"date":"2025-11-14T14:59:49","date_gmt":"2025-11-14T07:59:49","guid":{"rendered":"https:\/\/naviva.com.vn\/?p=2394"},"modified":"2025-12-16T15:33:19","modified_gmt":"2025-12-16T08:33:19","slug":"barycela-inj-varicella-vaccine-korea","status":"publish","type":"post","link":"https:\/\/naviva.com.vn\/en\/barycela-inj-varicella-vaccine-korea","title":{"rendered":"BARYCELA inj. Varicella Vaccine (Korea)"},"content":{"rendered":"<p><span style=\"font-size: 14pt; font-family: 'times new roman', times, serif; color: #000000;\"><b>Indications \/ Uses of BARYCELA inj. Varicella Vaccine<\/b><b><br \/>\n<\/b><span style=\"font-weight: 400;\">BARYCELA inj. is a live attenuated varicella (Varicella-Zoster Virus) vaccine derived from the attenuated MAV\/06 strain. It induces an immune response for the prevention of varicella infection.<\/span><\/span><\/p>\n<p><span style=\"font-weight: 400; font-size: 14pt; font-family: 'times new roman', times, serif; color: #000000;\">The vaccine is indicated for active immunization to prevent varicella in children from 12 months to 12 years of age.<\/span><\/p>\n<p><a href=\"https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-1-min.png\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-2384\" src=\"https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-1-min.png\" alt=\"\" width=\"2048\" height=\"1398\" srcset=\"https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-1-min.png 2048w, https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-1-min-300x205.png 300w, https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-1-min-648x442.png 648w, https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-1-min-768x524.png 768w, https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-1-min-1600x1092.png 1600w, https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-1-min-160x109.png 160w\" sizes=\"auto, (max-width: 2048px) 100vw, 2048px\" \/><\/a><\/p>\n<p style=\"text-align: center;\"><span style=\"font-weight: 400; font-family: 'times new roman', times, serif;\">Image: BARYCELA inj. Varicella Vaccine (Korea)<\/span><\/p>\n<h2><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Dosage and Administration of BARYCELA inj. Varicella Vaccine<\/b><\/span><\/h2>\n<p><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Dosage:<\/b><span style=\"font-weight: 400;\"> 0.5 mL of the vaccine after reconstitution.<\/span><\/span><\/p>\n<p><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Route of administration:<\/b><span style=\"font-weight: 400;\"> Subcutaneous injection; the recommended injection site is the lateral upper arm.<\/span><\/span><\/p>\n<h2><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Contraindications<\/b><\/span><\/h2>\n<p><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">This vaccine is contraindicated to the following patients:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Patients with known hypersensitivity to any component of the vaccine.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Patients with primary or acquired immunodeficiency due to conditions such as acute or chronic leukemia, lymphoma, or other disorders affecting the bone marrow or lymphatic system; immunodeficiency due to HIV\/AIDS; or cell-mediated immunodeficiency.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Patients receiving immunosuppressive therapy.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Patients with untreated active tuberculosis.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Pregnant women.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Patients with febrile respiratory illness or other febrile infectious diseases.<\/span><\/li>\n<\/ul>\n<h2><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Warnings and Precautions<\/b><\/span><\/h2>\n<p><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><span style=\"font-weight: 400;\">As with all injectable vaccines, appropriate emergency measures\u2014including injectable epinephrine (1:1000)\u2014and close medical supervision must be readily available in case an anaphylactic or hypersensitivity reaction occurs after vaccination. <\/span><b>This vaccine must NOT be administered intravenously (IV) or intramuscularly (IM).<\/b><\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">If acute conditions such as fever exceeding 38\u00b0C are present, postponement of vaccination should be considered.<\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">As with all varicella vaccines, this vaccine does not guarantee absolute prophylactic efficacy in all vaccine recipients.<\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Viral transmission of this vaccine strain was not identified in clinical trials. However, post-marketing studies of a similar vaccine have confirmed that, in rare cases, the virus may be transmitted through contact between healthy vaccinated individuals who develop a varicella-like rash and healthy but susceptible individuals. Transmission from vaccinated individuals without a varicella-like rash has also been reported.<\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Therefore, vaccinated individuals should avoid close contact for 6 weeks with the following high-risk susceptible groups:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><span style=\"font-weight: 400;\">Immunocompromised persons<\/span><\/span><\/span>&nbsp;<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><span style=\"font-weight: 400;\">Pregnant women without a medical history of varicella or laboratory evidence of immunity<\/span><\/span><\/span>&nbsp;<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Newborns of pregnant women without a medical history of varicella or laboratory evidence of immunity<\/span><\/li>\n<\/ul>\n<h2><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Adverse Reactions<\/b><\/span><\/h2>\n<p><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Very common (\u226510%)<\/b><\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Local reactions: pain, tenderness, erythema\/redness, induration.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Systemic reactions: cough, fever, anorexia\/loss of appetite.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Infections and infestations: nasopharyngitis.<\/span><\/li>\n<\/ul>\n<p><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Common (\u22651% to &lt;10%)<\/b><\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Local reactions: swelling, urticaria, pruritus.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Systemic reactions: fatigue, headache, vomiting\/nausea, constipation, abdominal pain, rash, dyspnea, allergic reactions.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Infections and infestations: bronchitis, gastroenteritis, hand-foot-mouth disease, pharyngitis, pneumonia, viral pneumonia, rhinitis, upper respiratory tract infection, viral infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Other: diarrhea, dermatitis, vesicular rash.<\/span><\/li>\n<\/ul>\n<p><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Uncommon (\u22650.1% to &lt;1%)<\/b><\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Systemic reactions: hypersensitivity.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Infections and infestations: bronchiolitis, viral gastritis, viral gastroenteritis, impetigo, otitis media, respiratory syncytial virus pneumonia, tonsillitis, gastritis.<\/span><\/li>\n<\/ul>\n<h2><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Drug Interactions<\/b><\/span><\/h2>\n<p><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">If blood or plasma transfusions, immunoglobulins, or varicella-zoster immunoglobulins have been administered, this vaccine should be given only after a minimum interval of 3 to 11 months, depending on the type, dose, and components of the blood products or immunoglobulin preparations.<\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">BARYCELA inj. must not be administered concomitantly with immunoglobulins, including varicella-zoster immunoglobulin. In addition, immunoglobulins must not be administered within 2 months after vaccination unless the benefits of immunoglobulin administration outweigh the benefits of vaccination.<\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Salicylates must not be used for 6 weeks after the administration of BARYCELA inj., as Reye\u2019s syndrome has been reported in association with salicylate use during natural varicella infection.<\/span><\/p>\n<p><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Overdose and Management<\/b><\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">No data are available regarding overdose with BARYCELA inj.; the recommended dose must not be exceeded.<\/span><\/p>\n<h2><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Precautions for Use<\/b><\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">The vaccine must be stored under refrigeration, and once reconstituted, it must be used immediately and within 30 minutes. The reconstituted vaccine must not be frozen.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">A separate sterile syringe and needle must be used for each individual to prevent the transmission of infectious diseases; needles must not be reused and must be appropriately discarded after use.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Only the enclosed diluent must be used for reconstitution.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Transferring the vaccine into another container may lead to errors and is undesirable for maintaining product quality.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">This vaccine must not be mixed with other medicinal products, including other viral vaccines.<\/span><\/li>\n<\/ul>\n<p><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Packaging<\/b><\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Box containing 1 vial of lyophilized vaccine + 1 vial of 0.7 ml diluent<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Box containing 10 vials of lyophilized vaccine + 10 vials of 0.7 ml diluent<\/span><\/li>\n<\/ul>\n<p><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Storage Method:<\/b><\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\">Store under refrigeration at 2\u20138\u00b0C in a light-shielded, airtight container.<\/span><\/p>\n<p><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Shelf Life:<\/b> <span style=\"font-weight: 400;\">The shelf life is 24 months from the date of manufacture.<\/span><\/span><\/p>\n<p><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Quality Standards:<\/b> <span style=\"font-weight: 400;\">TCCS (lyophilized powder) and current EP (accompanying diluent)<\/span><\/span><\/p>\n<h1><span style=\"color: #000000; font-size: 14pt; font-family: 'times new roman', times, serif;\"><b>Manufacturer: <\/b><b>GC Biopharma Corp. <\/b><span style=\"font-weight: 400;\">40 Sandan-gil, Hwasun-eup, Hwasun-gun, Jeollanam-do, Korea.<\/span><\/span><\/h1>\n<p><a href=\"https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-2-min.png\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-2386\" src=\"https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-2-min.png\" alt=\"\" width=\"2000\" height=\"2000\" srcset=\"https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-2-min.png 2000w, https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-2-min-235x235.png 235w, https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-2-min-508x508.png 508w, https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-2-min-150x150.png 150w, https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-2-min-768x768.png 768w, https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-2-min-1600x1600.png 1600w, https:\/\/naviva.com.vn\/wp-content\/uploads\/2025\/11\/vac-xin-thuy-dau-barycela-2-min-125x125.png 125w\" sizes=\"auto, (max-width: 2000px) 100vw, 2000px\" \/><\/a><\/p>\n<h3><span style=\"font-weight: 400; color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">NAVIVA GROUP \u2013 A TRUSTED PARTNER IN MARKETING AND DISTRIBUTION OF VACCINES &amp; BIOLOGICAL PRODUCTS<\/span><\/h3>\n<p><span style=\"color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\"><span style=\"font-weight: 400;\">Naviva Group is currently the exclusive distributor of the BARYCELA inj. Varicella Vaccine, manufactured by GC Biopharma (Korea). <\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">For further information, please contact:<\/span><\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">NAVIVA GROUP JOINT STOCK COMPANY<\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">NAM HUNG VIET VACCINE AND BIOLOGICAL PRODUCTS JOINT STOCK COMPANY<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">Address: 89 Nguyen Thi Thap Street, Him Lam Area, Tan Hung Ward, Ho Chi Minh City, Vietnam<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">Tel: 028 2223 2425<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400; color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">TUONG KHUE PHARMACEUTICAL JOINT STOCK COMPANY<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">Address: 33 Le Lai Street, Hai Chau Ward, Da Nang City, Vietnam<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">Tel: 0236 3538 666<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400; color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">WINBIO JOINT STOCK COMPANY<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">Address: K7TT1 \u2013 SH19, Starlake Urban Area, Xuan Dinh Ward, Hanoi Capital, Vietnam<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000; font-family: 'times new roman', times, serif; font-size: 14pt;\">Tel: 024 3795 6789<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\"><span style=\"font-weight: 400; color: #0000ff; font-family: 'times new roman', times, serif; font-size: 14pt;\">NAVIVA GROUP<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"color: #ff0000; font-family: 'times new roman', times, serif; font-size: 14pt;\"><i><span style=\"font-weight: 400;\">\u201cCommunity\u2019s Health Is Our Happiness!\u201d<\/span><\/i><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Indications \/ Uses of BARYCELA inj. Varicella Vaccine BARYCELA inj. is a live attenuated varicella (Varicella-Zoster Virus) vaccine derived from the attenuated MAV\/06 strain. It induces an immune response for the prevention of varicella infection. The vaccine is indicated for active immunization to prevent varicella in children from 12 months to 12 years of age. [&hellip;] <\/p>\n","protected":false},"author":4,"featured_media":2392,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[25],"tags":[],"class_list":["post-2394","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/naviva.com.vn\/en\/wp-json\/wp\/v2\/posts\/2394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/naviva.com.vn\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/naviva.com.vn\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/naviva.com.vn\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/naviva.com.vn\/en\/wp-json\/wp\/v2\/comments?post=2394"}],"version-history":[{"count":3,"href":"https:\/\/naviva.com.vn\/en\/wp-json\/wp\/v2\/posts\/2394\/revisions"}],"predecessor-version":[{"id":2471,"href":"https:\/\/naviva.com.vn\/en\/wp-json\/wp\/v2\/posts\/2394\/revisions\/2471"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/naviva.com.vn\/en\/wp-json\/wp\/v2\/media\/2392"}],"wp:attachment":[{"href":"https:\/\/naviva.com.vn\/en\/wp-json\/wp\/v2\/media?parent=2394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/naviva.com.vn\/en\/wp-json\/wp\/v2\/categories?post=2394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/naviva.com.vn\/en\/wp-json\/wp\/v2\/tags?post=2394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}